Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nigel Mackman

Showing results (191-200 of 397) with videos related to

Pageof 40
Sort By:
Thrombosis and Haemostasis|December 2, 2006
A non-anticoagulant synthetic pentasaccharide reduces inflammation in a murine model of kidney ischemia-reperfusion injuryRolf Dario Frank, Todd Holscher, Gernot Schabbauer, et al.
Annals of Hematology|November 24, 2018
Low extracellular vesicle-associated tissue factor activity in patients with persistent lupus anticoagulant and a history of thrombosisLena Hell, Cihan Ay, Florian Posch, et al.
The Annals of Thoracic Surgery|February 28, 2003
Tissue factor and thrombin mediate myocardial ischemia-reperfusion injuryAlbert J Chong, Timothy H Pohlman, Craig R Hampton, et al.
Blood|January 25, 2003
Regulation of tissue factor and inflammatory mediators by Egr-1 in a mouse endotoxemia modelRafal Pawlinski, Brian Pedersen, Bettina Kehrle, et al.
Plos One|December 2, 2021
Role of tissue factor in delayed bone repair induced by diabetic state in miceHiroki Ehara, Kohei Tatsumi, Yoshimasa Takafuji, et al.
Journal of Thrombosis and Haemostasis : JTH|September 22, 2023
"C1-inhibitor levels and Venous Thromboembolism: Results from a Mendelian Randomization Study": comment from Grover et alSteven P Grover, Linda Sundler Björkman, Sigrid K Brækkan, et al.
Haematologica|October 12, 2023
Tissue factor pathway inhibitor is associated with risk of venous thromboembolism and all-cause mortality in patients with cancerCornelia Englisch, Florian Moik, Johannes Thaler, et al.
Scientific Reports|March 1, 2016
Myeloid tissue factor does not modulate lung inflammation or permeability during experimental acute lung injuryCiara M Shaver, Brandon S Grove, Jennifer K Clune, et al.
Research and Practice in Thrombosis and Haemostasis|September 1, 2020
Evaluation of different commercial antibodies for their ability to detect human and mouse tissue factor by western blottingAxel Rosell, Bernhard Moser, Yohei Hisada, et al.
Journal of Inflammation (London, England)|June 19, 2015
Δ(9)-Tetrahydrocannabinol (THC) enhances lipopolysaccharide-stimulated tissue factor in human monocytes and monocyte-derived microvesiclesJulie C Williams, Thomas W Klein, Bruce A Goldberger, et al.
Pageof 40

Showing results (191-200 of 397) with videos related to

Sort By:
Pageof 40
Thrombosis and Haemostasis|December 2, 2006
A non-anticoagulant synthetic pentasaccharide reduces inflammation in a murine model of kidney ischemia-reperfusion injuryRolf Dario Frank, Todd Holscher, Gernot Schabbauer, et al.
Annals of Hematology|November 24, 2018
Low extracellular vesicle-associated tissue factor activity in patients with persistent lupus anticoagulant and a history of thrombosisLena Hell, Cihan Ay, Florian Posch, et al.
The Annals of Thoracic Surgery|February 28, 2003
Tissue factor and thrombin mediate myocardial ischemia-reperfusion injuryAlbert J Chong, Timothy H Pohlman, Craig R Hampton, et al.
Blood|January 25, 2003
Regulation of tissue factor and inflammatory mediators by Egr-1 in a mouse endotoxemia modelRafal Pawlinski, Brian Pedersen, Bettina Kehrle, et al.
Plos One|December 2, 2021
Role of tissue factor in delayed bone repair induced by diabetic state in miceHiroki Ehara, Kohei Tatsumi, Yoshimasa Takafuji, et al.
Journal of Thrombosis and Haemostasis : JTH|September 22, 2023
"C1-inhibitor levels and Venous Thromboembolism: Results from a Mendelian Randomization Study": comment from Grover et alSteven P Grover, Linda Sundler Björkman, Sigrid K Brækkan, et al.
Haematologica|October 12, 2023
Tissue factor pathway inhibitor is associated with risk of venous thromboembolism and all-cause mortality in patients with cancerCornelia Englisch, Florian Moik, Johannes Thaler, et al.
Scientific Reports|March 1, 2016
Myeloid tissue factor does not modulate lung inflammation or permeability during experimental acute lung injuryCiara M Shaver, Brandon S Grove, Jennifer K Clune, et al.
Research and Practice in Thrombosis and Haemostasis|September 1, 2020
Evaluation of different commercial antibodies for their ability to detect human and mouse tissue factor by western blottingAxel Rosell, Bernhard Moser, Yohei Hisada, et al.
Journal of Inflammation (London, England)|June 19, 2015
Δ(9)-Tetrahydrocannabinol (THC) enhances lipopolysaccharide-stimulated tissue factor in human monocytes and monocyte-derived microvesiclesJulie C Williams, Thomas W Klein, Bruce A Goldberger, et al.
Pageof 40